眼炎症の世界市場2019-2023

◆英語タイトル:Global Ocular Inflammation Treatment Market 2019-2023
◆商品コード:IRTNTR30329
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年11月21日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、眼炎症の世界市場について調査・分析し、市場概要、市場環境、眼炎症市場規模、製品別(コルチコステロイド、免疫抑制剤、抗感染剤、その他)分析、投薬経路別分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・眼炎症の世界市場概要
・眼炎症の世界市場環境
・眼炎症の世界市場動向
・眼炎症の世界市場規模
・眼炎症の世界市場:業界構造分析
・眼炎症の世界市場:製品別(コルチコステロイド、免疫抑制剤、抗感染剤、その他)
・眼炎症の世界市場:投薬経路別
・眼炎症の世界市場:地域別市場規模・分析
・眼炎症の北米市場規模・予測
・眼炎症のヨーロッパ・中東・アフリカ市場規模・予測
・眼炎症のアジア太平洋市場規模・予測
・眼炎症の主要国分析
・眼炎症の世界市場:意思決定フレームワーク
・眼炎症の世界市場:成長要因、課題
・眼炎症の世界市場:競争環境
・眼炎症の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、AbbVie、Bausch Health、Novartis、Pfizerなどです。
【レポートの概要】

About this market
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye. Technavio’s analysts have predicted that the ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
Market Overview
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
For the detailed list of factors that will drive and challenge the growth of the ocular inflammation treatment market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be concentrated and with the presence of several companies including AbbVie and Bausch Health the competitive environment is quite intense. Factors such as the growing awareness of eye care and the technological advances in drug delivery, will provide considerable growth opportunities to ocular inflammation treatment manufactures. AbbVie, Bausch Health, Novartis, and Pfizer are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be concentrated and with few companies constantly focusing to improve their market positions, the competitive environment among the players is quite intense’

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Corticosteroids – Market size and forecast 2018-2023
• Immunosuppressants – Market size and forecast 2018-2023
• Anti-infectives – Market size and forecast 2018-2023
• Other drug classes – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: MARKET SEGMENTATION BY ROA
• Market segmentation by RoA
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• Americas – Market size and forecast 2018-2023
• EMEA – Market size and forecast 2018-2023
• APAC – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie
• ALLERGAN
• Bausch Health
• Novartis
• Pfizer
PART 15: APPENDIX
• Research methodology
• List of abbreviations
PART 16: EXPLORE TECHNAVIO


Exhibit 01: Global ophthalmology drugs market
Exhibit 02: Segments of global ophthalmology drugs market
Exhibit 03: Global ocular inflammation treatment market: An overview
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Corticosteroids – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Corticosteroids – Year-over-year growth 2019-2023 (%)
Exhibit 22: Immunosuppressants – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Immunosuppressants – Year-over-year growth 2019-2023 (%)
Exhibit 24: Anti-infectives – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Anti-infectives – Year-over-year growth 2019-2023 (%)
Exhibit 26: Other drug classes – Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Other drug classes – Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Global ocular inflammation treatment market: Segmentation based on RoA
Exhibit 30: Market overview of global topical ocular inflammation treatment market
Exhibit 31: Market overview of global parenteral ocular inflammation treatment market
Exhibit 32: Market overview of global oral ocular inflammation treatment market
Exhibit 33: Customer landscape
Exhibit 34: Market share by geography 2018-2023 (%)
Exhibit 35: Geographic comparison
Exhibit 36: Americas – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Americas – Year-over-year growth 2019-2023 (%)
Exhibit 38: EMEA – Market size and forecast 2018-2023 ($ millions)
Exhibit 39: EMEA – Year-over-year growth 2019-2023 (%)
Exhibit 40: APAC – Market size and forecast 2018-2023 ($ millions)
Exhibit 41: APAC – Year-over-year growth 2019-2023 (%)
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Global prevalence of geriatric population
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: AbbVie – Vendor overview
Exhibit 52: AbbVie – Business segments
Exhibit 53: AbbVie – Organizational developments
Exhibit 54: AbbVie – Geographic focus
Exhibit 55: AbbVie – Key offerings
Exhibit 56: AbbVie – Key customers
Exhibit 57: ALLERGAN – Vendor overview
Exhibit 58: ALLERGAN – Business segments
Exhibit 59: ALLERGAN – Organizational developments
Exhibit 60: ALLERGAN – Geographic focus
Exhibit 61: ALLERGAN – Segment focus
Exhibit 62: ALLERGAN – Key offerings
Exhibit 63: ALLERGAN – Key customers
Exhibit 64: Bausch Health – Vendor overview
Exhibit 65: Bausch Health – Business segments
Exhibit 66: Bausch Health – Organizational developments
Exhibit 67: Bausch Health – Geographic focus
Exhibit 68: Bausch Health – Segment focus
Exhibit 69: Bausch Health – Key offerings
Exhibit 70: Bausch Health – Key customers
Exhibit 71: Novartis – Vendor overview
Exhibit 72: Novartis – Business segments
Exhibit 73: Novartis – Organizational developments
Exhibit 74: Novartis – Geographic focus
Exhibit 75: Novartis – Segment focus
Exhibit 76: Novartis – Key offerings
Exhibit 77: Novartis – Key customers
Exhibit 78: Pfizer – Vendor overview
Exhibit 79: Pfizer – Business segments
Exhibit 80: Pfizer – Organizational developments
Exhibit 81: Pfizer – Geographic focus
Exhibit 82: Pfizer – Segment focus
Exhibit 83: Pfizer – Key offerings
Exhibit 84: Pfizer – Key customers



【掲載企業】

AbbVie、Bausch Health、Novartis、Pfizer

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[眼炎症の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆